相似文献
1
Contemporary management of ventricular arrhythmias in heart failure.心力衰竭中心室性心律失常的当代管理
Am J Cardiovasc Dis. 2023 Aug 15;13(4):207-221. eCollection 2023.
2
Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.心力衰竭患者室性心律失常和植入式心脏复律除颤器治疗的方法。
Curr Opin Cardiol. 2013 May;28(3):337-43. doi: 10.1097/HCO.0b013e3283604420.
3
Advanced electrophysiologic mapping systems: an evidence-based analysis.先进的电生理标测系统：基于证据的分析
Ont Health Technol Assess Ser. 2006;6(8):1-101. Epub 2006 Mar 1.
4
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.多非利特可降低室性心律失常和植入式心脏复律除颤器治疗的频率。
J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.
5
[Antiarrhythmic therapy in patients with heart failure].心力衰竭患者的抗心律失常治疗
Ther Umsch. 2000 May;57(5):324-32. doi: 10.1024/0040-5930.57.5.324.
6
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用：基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
7
Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.经 ICD 电击后接受导管消融治疗室性心动过速的患者，其长期死亡率和心力衰竭住院率低于仅接受药物治疗的患者。
Heart Rhythm. 2014 Apr;11(4):533-40. doi: 10.1016/j.hrthm.2013.12.014. Epub 2013 Dec 11.
8
Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.伴有植入式心律转复除颤器（ICD）电击的室性心动过速：何时药物治疗以及何时消融
Curr Cardiol Rep. 2017 Sep 13;19(11):105. doi: 10.1007/s11886-017-0924-0.
9
Prevention and management of chronic heart failure with electrical therapy.心力衰竭电治疗的预防与管理
Am J Cardiol. 2003 May 8;91(9A):62F-73F. doi: 10.1016/s0002-9149(02)03340-4.
10
Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.介入电生理学及其在心律失常治疗中的作用。
Ann Acad Med Singap. 1998 Mar;27(2):248-54.
引用本文的文献
1
[Role of ventricular tachycardia ablation in patients with systolic heart failure].[室性心动过速消融在收缩性心力衰竭患者中的作用]
Herzschrittmacherther Elektrophysiol. 2025 Mar;36(1):10-20. doi: 10.1007/s00399-024-01064-4. Epub 2025 Jan 22.
本文引用的文献
1
The value of functional substrate mapping in ventricular tachycardia ablation.功能性基质标测在室性心动过速消融中的价值。
Heart Rhythm O2. 2022 Nov 2;4(2):134-146. doi: 10.1016/j.hroo.2022.10.013. eCollection 2023 Feb.
2
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
3
Isochronal late activation mapping of epicardial ventricular tachycardia in a patient with midventricular obstructive hypertrophic cardiomyopathy.一名患有心室中部梗阻性肥厚型心肌病患者的心外膜室性心动过速等时性晚期激动标测
HeartRhythm Case Rep. 2022 Mar 10;8(5):374-377. doi: 10.1016/j.hrcr.2022.03.001. eCollection 2022 May.
4
First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.心肌病伴埋藏式心脏复律除颤器患者中应用一线导管消融治疗单形性室性心动过速：PAUSE-SCD 随机试验。
Circulation. 2022 Jun 21;145(25):1839-1849. doi: 10.1161/CIRCULATIONAHA.122.060039. Epub 2022 May 4.
5
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.基质消融与抗心律失常药物治疗有症状性室性心动过速。
J Am Coll Cardiol. 2022 Apr 19;79(15):1441-1453. doi: 10.1016/j.jacc.2022.01.050.
6
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.室性心动过速消融的时机是否影响植入型心律转复除颤器患者的预后？来自多中心随机 PARTITA 试验的结果。
Circulation. 2022 Jun 21;145(25):1829-1838. doi: 10.1161/CIRCULATIONAHA.122.059598. Epub 2022 Apr 3.
7
Endocardial Scar-Homogenization With vs Without Epicardial Ablation in VT Patients With Ischemic Cardiomyopathy.缺血性心肌病室性心动过速患者中心内膜瘢痕均质化：有无心外膜消融的对比
JACC Clin Electrophysiol. 2022 Apr;8(4):453-461. doi: 10.1016/j.jacep.2021.12.011. Epub 2022 Feb 23.
8
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF.沙库巴曲缬沙坦对 PARADIGM-HF 研究人员报告的室性心律失常的影响。
Eur J Heart Fail. 2022 Mar;24(3):551-561. doi: 10.1002/ejhf.2419. Epub 2022 Jan 19.
9
Arrhythmogenic Remodeling in the Failing Heart.心律失常性重构在心力衰竭中的作用。
Cells. 2021 Nov 17;10(11):3203. doi: 10.3390/cells10113203.
10
Intra-aortic Balloon Pump for Acute-on-Chronic Heart Failure Complicated by Cardiogenic Shock.主动脉内球囊反搏在合并心原性休克的慢性心力衰竭急性加重期的应用
J Card Fail. 2022 Jul;28(7):1202-1216. doi: 10.1016/j.cardfail.2021.11.009. Epub 2021 Nov 11.
Zotero 插件